Search Results - "Sevostyanova, I. V."

Clinical and biochemical phenotypes in cardiorespiratory comorbidity by Prokofyeva, T. V., Bashkina, O. A., Polunina, O. S., Sevostyanova, I. V., Gritsenko, E. L.

“…   Objective:  to estimate the incidence of recurrent myocardial infarction, stroke, and mortality in patients with different phenotypes of myocardial…”
Get full text

Prognostic value of molecules of average mass in patients with chronic obstructive pulmonary disease by Prokofyeva, T. V., Polunina, O. S., Voronina, L. P., Polunina, E. A., Sevostyanova, I. V.

“…Background. Chronic obstructive pulmonary disease is a socially significant disease affecting patient’s quality of life. Assessment of endogenous intoxication…”
Get full text

Analysis of the links between endothelium-dependent vasodilation indicators and the levels of high-sensitivity C-reactive protein and fractalkine/CX3CL1 in patients with acute coronary syndrome by Polunina, E. A., Kuzmichev, K. Yu, Voronina, L. P., Polunina, O. S., Sevostyanova, I. V.

“…Objective: to study and analyze the links between endothelium-dependent vasodilation (EDV) indicators and the levels of fractalkine (FN/CX3CL1) and high…”
Get full text

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction by Polunina, O. S., Voronina, L. P., Sevostyanova, I. V., Polunina, E. A.

“…Objective: to analyze the level of neopterin in patients with chronic heart failure (CHF) with a preserved fraction ejection fraction depending on the stage of…”
Get full text

Assessment of endogenous intoxication based on the study of medium and low molecular weight substances in patients with myocardial infarction against a background of chronic obstructive pulmonary disease by Prokofieva, T. V., Polunina, O. S., Polunina, E. A., Sevostyanova, I. V., Voronina, P. N.

“…Introduction . Frequent comorbidity of chronic obstructive pulmonary disease and myocardial infarction is due to the commonality of a number…”
Get full text

PULMONARY HYPERTENSION IN PATIENTS WITH DIFFERENT FORMS OF CORONARY HEART DISEASE: CHARACTERISTICS OF LEFT VENTRICULAR-ARTERIAL INTERACTIONS by POLUNINA, O. S., MYASOEDOVA, E. I., SEVOSTYANOVA, I. V., KUDRYASHEVA, I. A., VORONINA, L. P.

“…This study was conducted in order to evaluate the frequency of pulmonary hypertension in patients with ischemic cardiomyopathy and patients with postinfarction…”
Get full text

Markers of myocardial fibrosis in patients with ischemic cardiomyopathy and atrial fibrillation by E I Myasoedova, E A Polunina, L P Voronina, I V Sevostyanova

“…This paper studied the biochemical and functional indices of myocardial fibrosis in patients with ischemic cardiomyopathy and atrial fibrillation. In the group…”
Get full text

The level of c-type natriuretic peptide in patients with respiratory cardial comorbidity, depending on genotypes of the gene of endothelial nitric oxide synthase by O S Polunina, A Kh Akhmineeva, I V Sevostyanova, L P Voronina

“…In this work we have studied the level of C-type natriuretic peptide in patients with respiratory cardiac comorbidities (COPD + HD, COPD + IHD), depending on…”
Get full text

FREE RADICAL MODIFICATION OF PROTEINS AND LIPID IN ATRIAL FIBRILLATION by M. O. Philippova, I. V. Sevostyanova, E. A. Polunina

“…At 105 patients with paroxysmal and permanent form of atrial fibrillation against the background of coronary heart disease (CHD) and without CHD were studied…”
Get full text

The level of the cardiac peptide NT-proBNP and indices of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy by E. I. Myasoedova, G. N. Muchambetova, I. V. Sevostyanova, O. S. Polunina, L. P. Voronina

“…This study focuses on the comparison of the level of NT-proBNP with indicators of the scale of assessment of clinical status in chronic heart failure patients…”
Get full text

Ventricular-arterial interaction in patients with is-chemic cardiomyopathy by E. I. Myasoedova, S. S. Sandzhieva, I. V. Sevostyanova, O. S. Polunina, L. V. Zaklyakova

“…This study examines the characteristics ventricular-arterial interaction and the efficiency of left ventricle in patients with ischemic cardiomyopathy. We…”
Get full text

INFLUENCE OF C-TERMINAL TELOPEPTIDE OF TYPE I COLLAGEN AT LINEAR AND VOLUMETRIC CHARACTERISTICS OF LEFT VENTRICLE IN PATIENTS WITH CHRONIC HEART FAILURE by L. P. Voronina, E. A. Polunina, I. V. Sevostyanova, D. O. Klimchuk, O. S. Polunina, N. YU. Perova

“…In this study linear and three-dimensional left ventricle characteristic de-pending on the level of C-terminal telopeptide of type I collagen of 112 ischemic…”
Get full text

Interrelations of the fraktalkin level and echocardi-oskopic indicators at the arterial hypertension, sten-ocardia tension and their combination by D. S. Tarasochkina, E. A. Polunina, I. V. Sevostyanova, L. P. Voronina, B. I. Kantemirova

“…To reveal the interrelation between the level of the fraktalkin plasma and indicators of the dopplerechocardiography (ECHO-CS) were examined 135 patients with…”
Get full text

CLINICAL AND DIAGNOSTIC FEATURES OF AORTIC STENOSIS by S. M. Gerasimenko, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina

“…Early diagnosis of aortic stenosis may begin with the identification of left ventricular hypertrophy by two-dimensional Doppler echocardiography. For aortic…”
Get full text

The evaluation of С-terminal telopeptide of type-i collagen level in patients with chronic heart failure along with atrial fibrillation and postinfarction cardiosclerosis by D. O. Klimchuk, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina, E. A. Polunina, T. V. Prokofieva

“…C-terminal telopeptide of type-I collagen level was studied in 112 chronic heart failure (CHF) patients and in 30 patients without heart failure. As a result,…”
Get full text

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity by A. Kh. Akhmineeva, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina

“…A correlation analysis to identify the relationship between markers of endothelial dysfunction (coefficient of endothelial function - EFC, type C natriuretic…”
Get full text

Vascular endothelial dysfunction and comorbid conditions in bronchial asthma by A. Kh. Akhmineeva, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina

“…We have examined 35 patients with bronchial asthma (BA), 35 patients with ischemic heart disease (IHD), 35 patients with arterial hypertension (AH), 40…”
Get full text

BIOCHEMICAL AND GENETIC ASPECTS OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION COMBINATION by O. S. Polunina, I. V. Sevostyanova, A. Kh. Akhmineeva, L. P. Voronina

“…The content of endothelium-1 and C-type natriuretic peptide in the blood plasma in correlation with the gene polymorphism of endothelial nitric oxide synthase…”
Get full text

CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE by A. Kh. Akhmineeva, O. S. Polunina, L. P. Voronina, I. V. Sevostyanova

“…In this paper we have carried out the diagnosis of the damage of the vascular endothelium in patients with ischemic heart disease (IHD) based on the study of…”
Get full text

THE ROLE OF FRACTALKINE AS A MARKER OF THE INFLAMMATORY ACTIVITY AT COMBINED RESPIRATORY CARDIAC PATHOLOGY by A. Kh. Akhmineeva, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina

“…In this research, the authors established the role of fractalkine as a marker of inflammatory activity at concomitant respiratory cardiac pathology, which…”
Get full text